Uncovering the Metabolic Origin of Aspartate for Tumor Growth Using an Integrated Molecular Deactivator
Nanoprobe
Metabolic pathway
Limiting
DOI:
10.1021/acs.nanolett.0c04520
Publication Date:
2020-12-11T08:53:29Z
AUTHORS (14)
ABSTRACT
Reprogrammed glucose metabolism is vital for cancer cells, but aspartate, an intermediate metabolic product, the limiting factor cell proliferation. However, due to complexity of pathways, it remains unclear whether primary source endogenous aspartate. Here, we report design innovative molecular deactivator, based on a multifunctional upconversion nanoprobe, explore link between and This deactivator mainly works in acidic, hypoxic tumor microenvironment deactivates multiple types transporters membranes upon illumination at 980 nm. Cancer proliferation vivo strongly inhibited by blocking transporters. Our experimental data confirm that cellular synthesis aspartate growth glucose-dependent. work also demonstrates untapped potential molecularly engineered nanoprobes discovering hidden pathways improving therapeutic efficacy conventional antitumor drugs.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (17)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....